Febrile Ulceronecrotic Mucha-Habermann Disease: Treatment with Infliximab and Intravenous Immunoglobulins and Review of the Literature

Publisher： Karger

E-ISSN： 1421-9832|225|4|344-348

ISSN： 1018-8665

Source： Dermatology, Vol.225, Iss.4, 2013-01, pp. : 344-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulins: A Valuable Asset in the Treatment of a Case of Septic Febrile Ulceronecrotic Mucha-Habermann Disease

By  

Dermatology, Vol. 215, Iss. 2, 2007-08 ,pp. : 164-165

Karger

Access to resources Recommend Favorite

A Case of Ulceronecrotic Mucha-Habermann Disease with Pulmonary Involvement

By  

Dermatology, Vol. 212, Iss. 4, 2006-05 ,pp. : 388-390

Karger

Access to resources Recommend Favorite

Febrile Ulceronecrotic Mucha Habermann Disease: Case Report of a Dark-Skinned Patient

By  

Case Reports in Dermatology, Vol. 5, Iss. 1, 2013-01 ,pp. : 4-10

Karger

Access to resources Recommend Favorite

Syphilis Mimicking Other Dermatological Diseases: Reactive Arthritis and Mucha-Habermann Disease

By  

Case Reports in Dermatology, Vol. 5, Iss. 1, 2013-01 ,pp. : 15-20

Karger

Access to resources Recommend Favorite

Treatment of Toxic Epidermal Necrolysis with the Combination of Infliximab and High-Dose Intravenous Immunoglobulin

By  

Dermatology, Vol. 224, Iss. 2, 2012-05 ,pp. : 134-139

Karger

Access to resources Recommend Favorite